|
- Bausch + Lomb Bolsters Pipeline with Acquisition of Whitecap . . .
Bausch + Lomb Bolsters Pipeline with Acquisition of Whitecap Biosciences | Bausch + Lomb CorporationGlaucoma is a chronic, progressive neurodegenerative disease that occurs when excessive eye pressure or other causes lead to damage of the optic nerve As one of the leading causes of preventable blindness, glaucoma affects about four million people in the United States, but if caught early, it
- Bausch + Lomb Receives European CE Mark Approval for Preloaded LuxLife . . .
VAUGHAN, Ontario -- (BUSINESS WIRE)--Bausch + Lomb Corporation (NYSE TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced CE Mark approval for the LuxLife full range of vision intraocular lens (IOL) The preloaded IOL provides patients with natural, continuous vision, from distance to near Today’s announcement reinforces
- Bausch + Lomb Launches Arise™ Orthokeratology Lens System in the United . . .
Bausch + Lomb Launches Arise™ Orthokeratology Lens System in the United States | Bausch + Lomb CorporationEngineered for precision and speed, Arise uses advanced algorithms to instantly interpret corneal topography images and recommend lens designs in seconds – no fitting set required It is designed for lens fitters of all experience levels and efficiently evaluates lens centration and
- Investor Relations | Bausch + Lomb Corporation
Investors Bausch + Lomb Corporation (NYSE TSX: BLCO) is a leading global eye health company that is dedicated to protecting and enhancing the gift of sight for millions of people around the world – from the moment of birth through every phase of life
- Bausch + Lomb Announces Voluntary Recall of enVista Aspire™, enVista . . .
Bausch + Lomb Announces Voluntary Recall of enVista Aspire™, enVista Envy™ and Certain enVista® Monofocal Intraocular Lenses | Bausch + Lomb CorporationTASS, a potential complication in any cataract surgery, is an inflammatory reaction inside the eye that can have a variety of causes When it occurs, this complication typically appears 12 – 48 hours after eye surgery All enVista TASS
- Bausch + Lomb Commercial and Manufacturing Locations
Contact information for Bausch + Lomb locations near you Any serious incidents, side effects, adverse reactions or product complaints should be reported here
- Bausch + Lomb Official Home Page
Bausch + Lomb is one of the world's largest suppliers of contact lenses, lens care products, prescription pharmaceuticals, intraocular lenses and other eye surgery products
- Bausch + Lomb Acquires AcuFocus, Inc. - Lomb Corporation
Bausch + Lomb Acquires AcuFocus, Inc | Bausch + Lomb CorporationAcuFocus has delivered breakthrough small aperture intraocular technology to address the diverse unmet needs in eye care, including the IC-8 ® Apthera ™ intraocular lens (IOL), which was approved by the U S Food and Drug Administration in July 2022 as the first and only small aperture non-toric extended depth of focus (EDOF
|
|
|